Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

SEC Form 4: Denbaars Steven sold $31,360 worth of shares (7,000 units at $4.48) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 250,545 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.